-
1
-
-
11844304978
-
Dimethylfumarate for psoriasis: More than a dietary curiosity
-
Mrowietz U, Asadullah K,. Dimethylfumarate for psoriasis: more than a dietary curiosity. Trends Mol Med 2005; 11: 43-8.
-
(2005)
Trends Mol Med
, vol.11
, pp. 43-48
-
-
Mrowietz, U.1
Asadullah, K.2
-
2
-
-
70249137988
-
European S3-guidelines on the systemic treatment of psoriasis vulgaris
-
Pathirana D, Ormerod AD, Saiag P, et al,. European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol 2009; 23 (Suppl. 2): 1-70.
-
(2009)
J Eur Acad Dermatol Venereol
, vol.23
, pp. 1-70
-
-
Pathirana, D.1
Ormerod, A.D.2
Saiag, P.3
-
3
-
-
0042413498
-
Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis
-
Hoefnagel JJ, Thio HB, Willemze R, et al,. Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis. Br J Dermatol 2003; 149: 363-9.
-
(2003)
Br J Dermatol
, vol.149
, pp. 363-369
-
-
Hoefnagel, J.J.1
Thio, H.B.2
Willemze, R.3
-
4
-
-
68149087714
-
Efficacy and safety of fumaric acid esters in the long-term treatment of psoriasis - A retrospective study (FUTURE)
-
Reich K, Thaci D, Mrowietz U, et al,. Efficacy and safety of fumaric acid esters in the long-term treatment of psoriasis-a retrospective study (FUTURE). J Dtsch Dermatol Ges 2009; 7: 603-11.
-
(2009)
J Dtsch Dermatol Ges
, vol.7
, pp. 603-611
-
-
Reich, K.1
Thaci, D.2
Mrowietz, U.3
-
5
-
-
74349131119
-
Treatment of severe, recalcitrant, chronic plaque psoriasis with fumaric acid esters: A prospective study
-
Wain EM, Darling MI, Pleass RD, et al,. Treatment of severe, recalcitrant, chronic plaque psoriasis with fumaric acid esters: a prospective study. Br J Dermatol 2010; 162: 427-34.
-
(2010)
Br J Dermatol
, vol.162
, pp. 427-434
-
-
Wain, E.M.1
Darling, M.I.2
Pleass, R.D.3
-
6
-
-
33644917994
-
Effects of monomethylfumarate on dendritic cell differentiation
-
Litjens NH, Rademaker M, Ravensbergen B, et al,. Effects of monomethylfumarate on dendritic cell differentiation. Br J Dermatol 2006; 154: 211-17.
-
(2006)
Br J Dermatol
, vol.154
, pp. 211-217
-
-
Litjens, N.H.1
Rademaker, M.2
Ravensbergen, B.3
-
7
-
-
0028089856
-
Fumaric acid derivatives evoke a transient increase in intracellular free calcium concentration and inhibit the proliferation of human keratinocytes
-
Thio HB, Zomerdijk TP, Oudshoorn C, et al,. Fumaric acid derivatives evoke a transient increase in intracellular free calcium concentration and inhibit the proliferation of human keratinocytes. Br J Dermatol 1994; 131: 856-61.
-
(1994)
Br J Dermatol
, vol.131
, pp. 856-861
-
-
Thio, H.B.1
Zomerdijk, T.P.2
Oudshoorn, C.3
-
8
-
-
74249094930
-
Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis
-
Griffiths CE, Strober BE, van de Kerkhof P, et al,. Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis. N Engl J Med 2010; 362: 118-28.
-
(2010)
N Engl J Med
, vol.362
, pp. 118-128
-
-
Griffiths, C.E.1
Strober, B.E.2
Van De Kerkhof, P.3
-
9
-
-
78651401370
-
Resolved psoriasis lesions retain expression of a subset of disease-related genes
-
Suarez-Farinas M, Fuentes-Duculan J, Lowes MA, et al,. Resolved psoriasis lesions retain expression of a subset of disease-related genes. J Invest Dermatol 2011; 131: 391-400.
-
(2011)
J Invest Dermatol
, vol.131
, pp. 391-400
-
-
Suarez-Farinas, M.1
Fuentes-Duculan, J.2
Lowes, M.A.3
-
10
-
-
71749085498
-
Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes
-
1022-10
-
Zaba LC, Suárez-Fariñas M, Fuentes-Duculan J, et al,. Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes. J Allergy Clin Immunol 2009; 124: 1022-10.e1-395.
-
(2009)
J Allergy Clin Immunol
, vol.124
, pp. e1-395
-
-
Zaba, L.C.1
Suárez-Fariñas, M.2
Fuentes-Duculan, J.3
-
12
-
-
79953686491
-
Fumarates vs. Methotrexate in moderate to severe chronic plaque psoriasis: A multicentre prospective randomized controlled clinical trial
-
Fallah Arani S, Neumann H, Hop WC, et al,. Fumarates vs. methotrexate in moderate to severe chronic plaque psoriasis: a multicentre prospective randomized controlled clinical trial. Br J Dermatol 2011; 164: 855-61.
-
(2011)
Br J Dermatol
, vol.164
, pp. 855-861
-
-
Fallah Arani, S.1
Neumann, H.2
Hop, W.C.3
-
13
-
-
84857904170
-
German S3-guidelines on the treatment of psoriasis vulgaris (short version)
-
Nast A, Boehncke WH, Mrowietz U, et al,. German S3-guidelines on the treatment of psoriasis vulgaris (short version). Arch Dermatol Res 2012; 304: 87-113.
-
(2012)
Arch Dermatol Res
, vol.304
, pp. 87-113
-
-
Nast, A.1
Boehncke, W.H.2
Mrowietz, U.3
-
14
-
-
79951727038
-
Definition of treatment goals for moderate to severe psoriasis: A European consensus
-
Mrowietz U, Kragballe K, Reich K, et al,. Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res 2011; 303: 1-10.
-
(2011)
Arch Dermatol Res
, vol.303
, pp. 1-10
-
-
Mrowietz, U.1
Kragballe, K.2
Reich, K.3
-
15
-
-
79958825496
-
Effective treatment of psoriasis with narrow-band UVB phototherapy is linked to suppression of the IFN and Th17 pathways
-
Racz E, Prens EP, Kurek D, et al,. Effective treatment of psoriasis with narrow-band UVB phototherapy is linked to suppression of the IFN and Th17 pathways. J Invest Dermatol 2011; 131: 1547-58.
-
(2011)
J Invest Dermatol
, vol.131
, pp. 1547-1558
-
-
Racz, E.1
Prens, E.P.2
Kurek, D.3
-
16
-
-
21644451881
-
Gene expression profiling in acute lymphoblastic leukemia (ALL)
-
Staal FJ,. Gene expression profiling in acute lymphoblastic leukemia (ALL). Lab Hematol 2004; 10: 178-81.
-
(2004)
Lab Hematol
, vol.10
, pp. 178-181
-
-
Staal, F.J.1
-
17
-
-
84859207992
-
Immunosuppressive effect of prolactin-induced protein
-
Sugiura S, Fujimiya M, Ebise H, et al,. Immunosuppressive effect of prolactin-induced protein. Chem Immunol Allergy 2012; 96: 100-7.
-
(2012)
Chem Immunol Allergy
, vol.96
, pp. 100-107
-
-
Sugiura, S.1
Fujimiya, M.2
Ebise, H.3
-
18
-
-
77952729449
-
Immunosuppressive effect of prolactin-induced protein: A new insight into its local and systemic role in chronic allergic contact dermatitis
-
Sugiura S, Fujimiya M, Ebise H, et al,. Immunosuppressive effect of prolactin-induced protein: a new insight into its local and systemic role in chronic allergic contact dermatitis. Br J Dermatol 2010; 162: 1286-93.
-
(2010)
Br J Dermatol
, vol.162
, pp. 1286-1293
-
-
Sugiura, S.1
Fujimiya, M.2
Ebise, H.3
-
19
-
-
33748444010
-
Assessment of epidermal subpopulations and proliferation in healthy skin, symptomless and lesional skin of spreading psoriasis
-
Korver JE, van Duijnhoven MW, Pasch MC, et al,. Assessment of epidermal subpopulations and proliferation in healthy skin, symptomless and lesional skin of spreading psoriasis. Br J Dermatol 2006; 155: 688-94.
-
(2006)
Br J Dermatol
, vol.155
, pp. 688-694
-
-
Korver, J.E.1
Van Duijnhoven, M.W.2
Pasch, M.C.3
-
20
-
-
0032978261
-
Keratin 15 expression in stratified epithelia: Downregulation in activated keratinocytes
-
Waseem A, Dogan B, Tidman N, et al,. Keratin 15 expression in stratified epithelia: downregulation in activated keratinocytes. J Invest Dermatol 1999; 112: 362-9.
-
(1999)
J Invest Dermatol
, vol.112
, pp. 362-369
-
-
Waseem, A.1
Dogan, B.2
Tidman, N.3
-
21
-
-
84856934199
-
Psoriasis and other complex trait dermatoses: From loci to functional pathways
-
Capon F, Burden AD, Trembath RC, et al,. Psoriasis and other complex trait dermatoses: from loci to functional pathways. J Invest Dermatol 2012; 132: 915-22.
-
(2012)
J Invest Dermatol
, vol.132
, pp. 915-922
-
-
Capon, F.1
Burden, A.D.2
Trembath, R.C.3
-
22
-
-
77953620903
-
Assessment of the psoriatic transcriptome in a large sample: Additional regulated genes and comparisons with in vitro models
-
Gudjonsson JE, Ding J, Johnston A, et al,. Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with in vitro models. J Invest Dermatol 2010; 130: 1829-40.
-
(2010)
J Invest Dermatol
, vol.130
, pp. 1829-1840
-
-
Gudjonsson, J.E.1
Ding, J.2
Johnston, A.3
-
23
-
-
84867887920
-
Expanding the psoriasis disease profile: Interrogation of the skin and serum of patients with moderate-to-severe psoriasis
-
Suarez-Farinas M, Li K, Fuentes-Duculan J, et al,. Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis. J Invest Dermatol 2012; 132: 2552-64.
-
(2012)
J Invest Dermatol
, vol.132
, pp. 2552-2564
-
-
Suarez-Farinas, M.1
Li, K.2
Fuentes-Duculan, J.3
-
24
-
-
79952136166
-
Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
-
Linker RA, Lee DH, Ryan S, et al,. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. Brain 2011; 134: 678-92.
-
(2011)
Brain
, vol.134
, pp. 678-692
-
-
Linker, R.A.1
Lee, D.H.2
Ryan, S.3
-
25
-
-
84873342691
-
Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis
-
van den Bogaard EH, Bergboer JG, Vonk-Bergers M, et al,. Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis. J Clin Invest 2013; 123: 917-27.
-
(2013)
J Clin Invest
, vol.123
, pp. 917-927
-
-
Van Den Bogaard, E.H.1
Bergboer, J.G.2
Vonk-Bergers, M.3
-
26
-
-
84883253431
-
'All things considered': Transcriptional regulation of T helper type 2 cell differentiation from precursor to effector activation
-
Zeng WP,. 'All things considered': transcriptional regulation of T helper type 2 cell differentiation from precursor to effector activation. Immunology 2013; 140: 31-8.
-
(2013)
Immunology
, vol.140
, pp. 31-38
-
-
Zeng, W.P.1
-
28
-
-
62749127946
-
Beta-defensin-2 protein is a serum biomarker for disease activity in psoriasis and reaches biologically relevant concentrations in lesional skin
-
Jansen PA, Rodijk-Olthuis D, Hollox EJ, et al,. Beta-defensin-2 protein is a serum biomarker for disease activity in psoriasis and reaches biologically relevant concentrations in lesional skin. PLOS ONE 2009; 4: e4725.
-
(2009)
PLOS ONE
, vol.4
, pp. e4725
-
-
Jansen, P.A.1
Rodijk-Olthuis, D.2
Hollox, E.J.3
-
29
-
-
84885793123
-
Effects of fumaric acid esters on blood-brain barrier tight junction proteins
-
Benardais K, Pul R, Singh V, et al,. Effects of fumaric acid esters on blood-brain barrier tight junction proteins. Neurosci Lett 2013; 555: 165-70.
-
(2013)
Neurosci Lett
, vol.555
, pp. 165-170
-
-
Benardais, K.1
Pul, R.2
Singh, V.3
-
30
-
-
84866355653
-
Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis
-
Fox RJ, Miller DH, Phillips JT, et al,. Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis. N Engl J Med 2012; 367: 1087-97.
-
(2012)
N Engl J Med
, vol.367
, pp. 1087-1097
-
-
Fox, R.J.1
Miller, D.H.2
Phillips, J.T.3
-
31
-
-
84866423965
-
Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis
-
Gold R, Kappos L, Arnold DL, et al,. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med 2012; 367: 1098-107.
-
(2012)
N Engl J Med
, vol.367
, pp. 1098-1107
-
-
Gold, R.1
Kappos, L.2
Arnold, D.L.3
-
32
-
-
69949187131
-
NGF and its receptor system: A new dimension in the pathogenesis of psoriasis and psoriatic arthritis
-
Raychaudhuri SK, Raychaudhuri SP,. NGF and its receptor system: a new dimension in the pathogenesis of psoriasis and psoriatic arthritis. Ann N Y Acad Sci 2009; 1173: 470-7.
-
(2009)
Ann N y Acad Sci
, vol.1173
, pp. 470-477
-
-
Raychaudhuri, S.K.1
Raychaudhuri, S.P.2
-
33
-
-
84860530952
-
Nrf2 links epidermal barrier function with antioxidant defense
-
Schafer M, Farwanah H, Willrodt AH, et al,. Nrf2 links epidermal barrier function with antioxidant defense. EMBO Mol Med 2012; 4: 364-79.
-
(2012)
EMBO Mol Med
, vol.4
, pp. 364-379
-
-
Schafer, M.1
Farwanah, H.2
Willrodt, A.H.3
-
34
-
-
80055106751
-
Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells
-
Ghoreschi K, Bruck J, Kellerer C, et al,. Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells. J Exp Med 2011; 208: 2291-303.
-
(2011)
J Exp Med
, vol.208
, pp. 2291-2303
-
-
Ghoreschi, K.1
Bruck, J.2
Kellerer, C.3
-
35
-
-
33947265597
-
Dimethylfumarate induces immunosuppression via glutathione depletion and subsequent induction of heme oxygenase 1
-
Lehmann JC, Listopad JJ, Rentzsch CU, et al,. Dimethylfumarate induces immunosuppression via glutathione depletion and subsequent induction of heme oxygenase 1. J Invest Dermatol 2007; 127: 835-45.
-
(2007)
J Invest Dermatol
, vol.127
, pp. 835-845
-
-
Lehmann, J.C.1
Listopad, J.J.2
Rentzsch, C.U.3
-
36
-
-
84899482285
-
Glutathione-S-transferase T1 genotyping and phenotyping in psoriasis patients receiving treatment with oral fumaric acid esters
-
Gambichler T, Kreuter A, Susok L, et al,. Glutathione-S-transferase T1 genotyping and phenotyping in psoriasis patients receiving treatment with oral fumaric acid esters. J Eur Acad Dermatol Venereol 2014; 28: 574-80.
-
(2014)
J Eur Acad Dermatol Venereol
, vol.28
, pp. 574-580
-
-
Gambichler, T.1
Kreuter, A.2
Susok, L.3
-
37
-
-
0345732760
-
Dimethylfumarate is a potent inducer of apoptosis in human T cells
-
Treumer F, Zhu K, Glaser R, et al,. Dimethylfumarate is a potent inducer of apoptosis in human T cells. J Invest Dermatol 2003; 121: 1383-8.
-
(2003)
J Invest Dermatol
, vol.121
, pp. 1383-1388
-
-
Treumer, F.1
Zhu, K.2
Glaser, R.3
-
38
-
-
1642329197
-
Monomethylfumarate affects polarization of monocyte-derived dendritic cells resulting in down-regulated Th1 lymphocyte responses
-
Litjens NH, Rademaker M, Ravensbergen B, et al,. Monomethylfumarate affects polarization of monocyte-derived dendritic cells resulting in down-regulated Th1 lymphocyte responses. Eur J Immunol 2004; 34: 565-75.
-
(2004)
Eur J Immunol
, vol.34
, pp. 565-575
-
-
Litjens, N.H.1
Rademaker, M.2
Ravensbergen, B.3
-
39
-
-
11144325701
-
Identification of anti-inflammatory drugs according to their capacity to suppress type-1 and type-2 T cell profiles
-
Moed H, Stoof TJ, Boorsma DM, et al,. Identification of anti-inflammatory drugs according to their capacity to suppress type-1 and type-2 T cell profiles. Clin Exp Allergy 2004; 34: 1868-75.
-
(2004)
Clin Exp Allergy
, vol.34
, pp. 1868-1875
-
-
Moed, H.1
Stoof, T.J.2
Boorsma, D.M.3
-
40
-
-
84872605849
-
Epidermal inactivation of the glucocorticoid receptor triggers skin barrier defects and cutaneous inflammation
-
Sevilla LM, Latorre V, Sanchis A, et al,. Epidermal inactivation of the glucocorticoid receptor triggers skin barrier defects and cutaneous inflammation. J Invest Dermatol 2013; 133: 361-70.
-
(2013)
J Invest Dermatol
, vol.133
, pp. 361-370
-
-
Sevilla, L.M.1
Latorre, V.2
Sanchis, A.3
-
41
-
-
84885961162
-
Pituitary tumor transforming gene 1 induces tumor necrosis factor-alpha production from keratinocytes: Implication for involvement in the pathophysiology of psoriasis
-
Ishitsuka Y, Kawachi Y, Maruyama H, et al,. Pituitary tumor transforming gene 1 induces tumor necrosis factor-alpha production from keratinocytes: implication for involvement in the pathophysiology of psoriasis. J Invest Dermatol 2013; 133: 2566-75.
-
(2013)
J Invest Dermatol
, vol.133
, pp. 2566-2575
-
-
Ishitsuka, Y.1
Kawachi, Y.2
Maruyama, H.3
-
42
-
-
77951877914
-
IkappaBzeta regulates T(H)17 development by cooperating with ROR nuclear receptors
-
Okamoto K, Iwai Y, Oh-Hora M, et al,. IkappaBzeta regulates T(H)17 development by cooperating with ROR nuclear receptors. Nature 2010; 464: 1381-5.
-
(2010)
Nature
, vol.464
, pp. 1381-1385
-
-
Okamoto, K.1
Iwai, Y.2
Oh-Hora, M.3
-
43
-
-
3142581432
-
Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta
-
Yamamoto M, Yamazaki S, Uematsu S, et al,. Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta. Nature 2004; 430: 218-22.
-
(2004)
Nature
, vol.430
, pp. 218-222
-
-
Yamamoto, M.1
Yamazaki, S.2
Uematsu, S.3
|